SCHEMBL614073

SCHEMBL614073

CC1CC(=O)CC(C)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL622881 1.00
SCHEMBL569096 1.00
SCHEMBL15772520 1.00
SCHEMBL15700748 0.84
SCHEMBL16795479 0.78 SMN1; SMN2 (0.36)
SCHEMBL16795485 0.78 SMN1; SMN2 (0.36)
SCHEMBL17068004 0.78 SMN1; SMN2 (0.36)
SCHEMBL21114911 0.77 SMN1; SMN2 (0.57)
SCHEMBL16795480 0.77 SMN1; SMN2 (0.34)
SCHEMBL16795489 0.77 SMN1; SMN2 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0230627-B1 OXIME ESTERS OF SUBSTITUTED QUINOLINE-8-CARBOXYLIC ACIDS AND THEIR USE AS HERBICIDES BASF Aktiengesellschaft (DE) 1992-03-04 EP claimed
US-20260138998-A1 GLP-1 RECEPTOR AGONISTS AND METHODS OF USE MERCK SHARP & DOHME LLC (US) 2026-05-21 US disclosed
EP-4743175-A1 COMPOUNDS, COMPOSITIONS, AND METHODS Aconcagua Bio, Inc. (US) 2026-05-20 EP disclosed
EP-4735439-A1 KRAS INHIBITORS Bristol-Myers Squibb Company (US) 2026-05-06 EP disclosed
EP-3950676-B1 PREPARATION METHOD FOR AMIDE COMPOUNDS AND APPLICATION THEREOF IN FIELD OF MEDICINE SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD (CN) 2026-04-08 EP disclosed
US-12595267-B2 Preparation method for amide compound and application thereof in field of medicine SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO., LTD. (CN) 2026-04-07 US disclosed
EP-4482579-B1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY LHOTSE BIO INC (US) 2026-02-18 EP disclosed
EP-3950682-B1 PREPARATION METHOD FOR AMIDE COMPOUNDS AND USE THEREOF IN MEDICAL FIELD SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD (CN) 2026-02-11 EP disclosed
US-12473298-B2 Amide compounds, preparation method therefor, and use thereof in the medical field SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO., LTD. (CN) 2025-11-18 US disclosed
US-12428375-B2 Compounds and compositions for treating conditions associated with LPA receptor activity LHOTSE BIO, INC. (US) 2025-09-30 US disclosed
EP-0579304-A1 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis MERCK FROSST CANADA INC. (CA) 1994-01-19 EP disclosed
WO-1994000444-A1 HETEROARYLNAPHTHALENES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS MERCK FROSST CANADA INC. (CA) 1994-01-06 WO disclosed
US-5227399-A Pyranylphenyl naphthalene lactones as inhibitors of leukotriene biosynthesis MERCK FROSST CANADA, INC. (CA) 1993-07-13 US disclosed
EP-0501579-A1 Naphthalene lactones as inhibitors of leukotriene biosynthesis MERCK FROSST CANADA INC. (CA) 1992-09-02 EP disclosed
EP-0501578-A1 Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis MERCK FROSST CANADA INC. (CA) 1992-09-02 EP disclosed
US-5098930-A Inhibitors of lipoxygenase for treatment of diseases mediated with leukotrienes IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-03-24 US disclosed
EP-0230627-B1 OXIME ESTERS OF SUBSTITUTED QUINOLINE-8-CARBOXYLIC ACIDS AND THEIR USE AS HERBICIDES BASF Aktiengesellschaft (DE) 1992-03-04 EP disclosed
EP-0375404-A2 Heterocyclic derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-06-27 EP disclosed
US-4808212-A Oxime esters of substituted quinoline-8-carboxylic acids and use thereof as herbicides BASF AKTIENGESELLSCHAFT (DE) 1989-02-28 US disclosed
EP-0230627-A1 Oxime esters of substituted quinoline-8-carboxylic acids and their use as herbicides BASF Aktiengesellschaft (DE) 1987-08-05 EP disclosed